Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in NASH-related Cirrhosis
NCT02234440Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Sep 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of metformin in Cirrhosis (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Reduction of portal pressure (HVPG) at 1 year. Started Sep 2014; status: completed.
02
Drugs
metformin
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on NCT02234440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02234440.